
18 Nov Science & Networking at The Liver Meeting 2019
Congrats Marc and all authors for this excellent work, which has been selected as a Presidential Poster of Distinction by the American Association for the Study of Liver Disease (AASLD). Posters of Distinction are classified as being in the top 10% of all accepted poster abstracts and receive special recognition in the Poster Hall. It has been presented in the Basic Fibrosis Research and Stellate Cell Biology Session, at The Liver Meeting 2019 (Boston, Massachusetts).
This abstract has also been selected by the AASLD Liver Fibrosis Special Interest Group to be presented as an Oral Communication at the TechBar of the Liver Meeting 2019.
CPEB4-driven PFKFB3-mediated metabolic reprogramming is essential for hepatic stellate cell activation and liver fibrosis: A novel druggable target
Mejias M, Gallego J, Naranjo-Suarez S, Ramirez M, Pell N, Manzano A, Bartrons R, Mendez R, Fernandez M
Corresponding author: Mercedes Fernandez
Hepatology 2019; 70 (Suppl):1444A